Global Patient-derived Xenograft (PDX) Models Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Patient-derived Xenograft (PDX) Models market size will reach 451.56 Million USD in 2025 and is projected to reach 777.92 Million USD by 2032, with a CAGR of 8.08% (2025-2032). Notably, the China Patient-derived Xenograft (PDX) Models market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Patient-derived xenograft (PDX) models are a type of preclinical research tool used in oncology and cancer research. These models involve transplanting tumor tissues or cells directly from cancer patients into immunodeficient mice or other animal models. PDX models aim to mimic the specific characteristics and behavior of a patient＇s tumor, allowing researchers to study its growth, response to treatments, and underlying biology in a controlled laboratory setting. PDX models are valuable for drug development and personalized medicine approaches, as they can help identify and test potential therapies and assess how an individual patient＇s cancer may respond to different treatments. These models bridge the gap between in vitro cell culture studies and human clinical trials, enabling researchers to make more informed decisions about treatment strategies and drug development based on a tumor＇s real-world behavior.
The major global suppliers of Patient-derived Xenograft (PDX) Models include Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo, Charles River Laboratories, Pharmatest Services, Urosphere, MEDICILON, Horizon Discovery, Shanghai Model Organisms Center, GemPharmatech, LIDE Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Patient-derived Xenograft (PDX) Models. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Patient-derived Xenograft (PDX) Models market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Patient-derived Xenograft (PDX) Models market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Patient-derived Xenograft (PDX) Models industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Patient-derived Xenograft (PDX) Models Include:
Crown Bioscience
Champions Oncology
Wuxi Apptec
The Jackson Laboratory
EPO Berlin-Buch
Oncodesign
Xentech
Envigo
Charles River Laboratories
Pharmatest Services
Urosphere
MEDICILON
Horizon Discovery
Shanghai Model Organisms Center
GemPharmatech
LIDE Biotech
Patient-derived Xenograft (PDX) Models Product Segment Include:
Mouse Model
Rat Model
Patient-derived Xenograft (PDX) Models Product Application Include:
Preclinical Drug development
Biomarker Analysis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Patient-derived Xenograft (PDX) Models Industry PESTEL Analysis
Chapter 3: Global Patient-derived Xenograft (PDX) Models Industry Porter's Five Forces Analysis
Chapter 4: Global Patient-derived Xenograft (PDX) Models Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Patient-derived Xenograft (PDX) Models Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Patient-derived Xenograft (PDX) Models Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Patient-derived Xenograft (PDX) Models Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Patient-derived Xenograft (PDX) Models market size will reach 451.56 Million USD in 2025 and is projected to reach 777.92 Million USD by 2032, with a CAGR of 8.08% (2025-2032). Notably, the China Patient-derived Xenograft (PDX) Models market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Patient-derived xenograft (PDX) models are a type of preclinical research tool used in oncology and cancer research. These models involve transplanting tumor tissues or cells directly from cancer patients into immunodeficient mice or other animal models. PDX models aim to mimic the specific characteristics and behavior of a patient＇s tumor, allowing researchers to study its growth, response to treatments, and underlying biology in a controlled laboratory setting. PDX models are valuable for drug development and personalized medicine approaches, as they can help identify and test potential therapies and assess how an individual patient＇s cancer may respond to different treatments. These models bridge the gap between in vitro cell culture studies and human clinical trials, enabling researchers to make more informed decisions about treatment strategies and drug development based on a tumor＇s real-world behavior.
The major global suppliers of Patient-derived Xenograft (PDX) Models include Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo, Charles River Laboratories, Pharmatest Services, Urosphere, MEDICILON, Horizon Discovery, Shanghai Model Organisms Center, GemPharmatech, LIDE Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Patient-derived Xenograft (PDX) Models. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Patient-derived Xenograft (PDX) Models market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Patient-derived Xenograft (PDX) Models market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Patient-derived Xenograft (PDX) Models industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Patient-derived Xenograft (PDX) Models Include:
Crown Bioscience
Champions Oncology
Wuxi Apptec
The Jackson Laboratory
EPO Berlin-Buch
Oncodesign
Xentech
Envigo
Charles River Laboratories
Pharmatest Services
Urosphere
MEDICILON
Horizon Discovery
Shanghai Model Organisms Center
GemPharmatech
LIDE Biotech
Patient-derived Xenograft (PDX) Models Product Segment Include:
Mouse Model
Rat Model
Patient-derived Xenograft (PDX) Models Product Application Include:
Preclinical Drug development
Biomarker Analysis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Patient-derived Xenograft (PDX) Models Industry PESTEL Analysis
Chapter 3: Global Patient-derived Xenograft (PDX) Models Industry Porter's Five Forces Analysis
Chapter 4: Global Patient-derived Xenograft (PDX) Models Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Patient-derived Xenograft (PDX) Models Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Patient-derived Xenograft (PDX) Models Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Patient-derived Xenograft (PDX) Models Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Patient-derived Xenograft (PDX) Models Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Patient-derived Xenograft (PDX) Models Product by Type
- 1.2.1 Mouse Model
- 1.2.2 Rat Model
- 1.3 Patient-derived Xenograft (PDX) Models Product by Application
- 1.3.1 Preclinical Drug development
- 1.3.2 Biomarker Analysis
- 1.4 Global Patient-derived Xenograft (PDX) Models Market Size Analysis (2020-2032)
- 1.5 Patient-derived Xenograft (PDX) Models Market Development Status and Trends
- 1.5.1 Patient-derived Xenograft (PDX) Models Industry Development Status Analysis
- 1.5.2 Patient-derived Xenograft (PDX) Models Industry Development Trends Analysis
- 2 Patient-derived Xenograft (PDX) Models Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Patient-derived Xenograft (PDX) Models Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Patient-derived Xenograft (PDX) Models Market Analysis by Country
- 4.1 Global Patient-derived Xenograft (PDX) Models Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Patient-derived Xenograft (PDX) Models Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Patient-derived Xenograft (PDX) Models Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.5 China Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.6 France Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.14 India Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Patient-derived Xenograft (PDX) Models Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Patient-derived Xenograft (PDX) Models Market Revenue by Key Suppliers (2021-2025)
- 5.2 Global Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Patient-derived Xenograft (PDX) Models Market Analysis by Type
- 6.1 Global Patient-derived Xenograft (PDX) Models Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Patient-derived Xenograft (PDX) Models Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Crown Bioscience
- 7.1.1 Crown Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Crown Bioscience Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Champions Oncology
- 7.2.1 Champions Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Champions Oncology Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Wuxi Apptec
- 7.3.1 Wuxi Apptec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 The Jackson Laboratory
- 7.4.1 The Jackson Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 EPO Berlin-Buch
- 7.5.1 EPO Berlin-Buch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Oncodesign
- 7.6.1 Oncodesign Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Oncodesign Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Xentech
- 7.7.1 Xentech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Xentech Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.7.3 Xentech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Envigo
- 7.8.1 Envigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Envigo Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.8.3 Envigo Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Charles River Laboratories
- 7.9.1 Charles River Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Pharmatest Services
- 7.10.1 Pharmatest Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Pharmatest Services Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Urosphere
- 7.11.1 Urosphere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Urosphere Patient-derived Xenograft (PDX) Models Product Portfolio
- 7.11.3 Urosphere Patient-derived Xenograft (PDX) Models Market Dat
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
